首页> 外国专利> RELEVANCE OF ACHIEVED LEVELS OF MARKERS OF SYSTEMIC INFLAMMATION FOLLOWING TREATMENT

RELEVANCE OF ACHIEVED LEVELS OF MARKERS OF SYSTEMIC INFLAMMATION FOLLOWING TREATMENT

机译:治疗后全身炎症反应指标水平的相关性

摘要

The invention involves, inter alia, the use of markers of systemic inflammation to determine whether or not an individual undergoing treatment with a cardiovascular agent to reduce the risk of a future cardiovascular event will benefit from continued treatment with the cardiovascular agent. Further, this invention describes the use of markers of systemic inflammation to evaluate the efficacy of treatment and to assist physicians in deciding on the course of a treatment in an individual at risk of future cardiovascular events.
机译:本发明尤其涉及全身性炎症标志物的使用,以确定接受心血管药物治疗以降低未来发生心血管事件风险的个体是否会受益于心血管药物的持续治疗。此外,本发明描述了全身性炎症标志物在评估治疗功效和协助医师决定有未来心血管事件风险的个体的治疗过程中的用途。

著录项

  • 公开/公告号US2016266146A1

    专利类型

  • 公开/公告日2016-09-15

    原文格式PDF

  • 申请/专利权人 THE BRIGHAM AND WOMENS HOSPITAL INC.;

    申请/专利号US201514886626

  • 发明设计人 PAUL M. RIDKER;

    申请日2015-10-19

  • 分类号G01N33/68;A61K31/22;A61K31/40;G01N33/92;

  • 国家 US

  • 入库时间 2022-08-21 14:38:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号